mycamine
Mycamine (Micafungin Sodium) is an echinocandin antifungal used to treat Candidemia.
Micafungin Sodium · by Fujisawa Hlthcare
Available as a generic: Micafungin Sodium
Key facts
- Active ingredient
- Micafungin Sodium
- Drug class
- Echinocandin Antifungal
- Form
- Injectable
- Strength
- Micafungin Sodium 50MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- candidemia
- Manufacturer
- Fujisawa Hlthcare
- FDA application
- NDA021754
Drug class
May treat (source: NIH RxClass)
See how Mycamine ranks — best-rated echinocandin antifungal for:
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Mycamine treat?
- Mycamine (Micafungin Sodium) may be used to treat candidemia, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Mycamine?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Mycamine. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Mycamine?
- Mycamine is marketed by Fujisawa Hlthcare. You can see Fujisawa Hlthcare's full profile, rating, and other products on pharmaranks.
- Is Mycamine a brand-name or generic drug?
- Mycamine is a brand-name product with the active ingredient Micafungin Sodium. Lower-cost generic equivalents containing Micafungin Sodium are available — ask your pharmacist.
- Is Mycamine available over the counter?
- No. Mycamine is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Mycamine come in?
- Mycamine is currently marketed as injectable, per the FDA's National Drug Code Directory.
- What class of drug is Mycamine?
- Mycamine is classified as echinocandin antifungal, per the FDA's Established Pharmacologic Class.
- Is Mycamine FDA-registered?
- Mycamine is on record with the U.S. FDA under application number NDA021754. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about MICAFUNGIN SODIUM
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 1,543 reports naming MICAFUNGIN SODIUM — the active ingredient in Mycamine, and the FDA flagged 99% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- pyrexia204 reports
- febrile neutropenia177 reports
- pneumonia125 reports
- sepsis110 reports
- diarrhoea106 reports
- platelet count decreased88 reports
- white blood cell count decreased75 reports
- anaemia69 reports
Read these as a signal, not a rate. A report does not mean MICAFUNGIN SODIUM caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Mycamine head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
mycamine
New